ORIZON (ORVR3) Main Indicators
Basic Data - ORVR3
| Company | ORIZON |
| Corporate Name | ORIZON VALORIZACAO DE RESIDUOS S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Atuação na cadeia de gestão de resíduos: tratamento e destinação final de resíduos; exploração do biogás. energia e créditos de carbono; beneficiamento de resíduos; e serviços de engenharia ambiental |
| Share | ORVR3 |
| Quote Date | 11/19/2024 |
| Share Type | ON |
| Last Closing | R$ 45.41 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 37.26 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Utilidade Pública |
| Subsector | Água e Saneamento |
| Segment | Água e Saneamento |
| Participation Indexes | IBRA, IGC, IGCT, IGNM, ITAG, SMLL, UTIL |
| Updated 11/21/2024 | |
Relative Prices - ORVR3
| Price/Earnings | 23.55 |
| Price/SBV | 4.80 |
| Price/Net Sales | 4.32 |
| Price/CFO | 35.30 |
| Price/FCF | -11.01 |
| Price/Total Assets | 1.13 |
| Price/EBIT | 11.94 |
| Price/Working Capital | 6.75 |
| Price/NCAV | -1.90 |
| EV/EBIT | 15.82 |
| EV/EBITDA | 10.92 |
| EV/Net Sales | 5.73 |
| EV/CFO | 46.79 |
| EV/FCF | -14.59 |
| EV/Total Assets | 1.50 |
| Company Market Cap | R$ 3.77 B |
| Enterprise Value | R$ 4.99 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 45.41 |
| Share Price Date | 11/19/2024 |
| Dividend Yield | 0.00% |
| Updated 11/21/2024 | |
Income Statement - ORVR3
| Net Revenue | R$ 871.85 M |
| Gross Result | R$ 382.49 M |
| EBIT | R$ 315.51 M |
| Depreciation and Amortization | - R$ 141.78 M |
| EBITDA | R$ 457.29 M |
| Net Profit | R$ 159.92 M |
| Net Profit/Share | R$ 1.93 |
| Updated 11/13/2024 | |
| Net Revenue | R$ 249.07 M |
| Gross Result | R$ 124.93 M |
| EBIT | R$ 91.09 M |
| Depreciation and Amortization | - R$ 39.87 M |
| EBITDA | R$ 130.96 M |
| Net Profit | R$ 37.08 M |
| Profit/Share | R$ 0.45 |
| Updated 11/13/2024 | |
Price and Volume Behavior - ORVR3
| Lowest Price 52 weeks | R$ 32.82 |
| Highest Price 52 weeks | R$ 49.50 |
| Variation 2024 | 27.02% |
| Variation 1 year | 21.13% |
| Variation 2 years(total) | 15.64% |
| Variation 2 years(yearly) | 7.51% |
| Variation 3 years(total) | 69.63% |
| Variation 3 years(yearly) | 19.24% |
| Variation 4 years(total) | - |
| Variation 4 years(yearly) | - |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 26.19 M |
| Updated 11/21/2024 | |
Returns and Margins - ORVR3
| Return on Initial Tangible Capital | 15.94% |
| Return on Initial Invested Capital | 13.34% |
| Pre-Tax Return on Initial Tangible Capital | 24.15% |
| Pre-Tax Return on Initial Invested Capital | 20.21% |
| Return on Initial Shareholder´s Equity | 25.90% |
| Return on Initial Asset | 7.14% |
| Gross Margin | 43.87% |
| Net Margin | 18.34% |
| EBIT Margin | 36.19% |
| EBITDA Margin | 52.45% |
| Initial Asset Turnover | 0.39 |
| Financial Leverage | 4.24 |
| Liabilities/Net Worth | 3.24 |
| Net Debt/EBITDA | 2.68 |
| Updated 11/13/2024 | |
Balance Sheet - ORVR3
| Cash and Cash Equivalents | R$ 668.55 M |
| Total Assets | R$ 3.33 B |
| Short-Term Debt | R$ 308.68 M |
| Long-Term Debt | R$ 1.59 B |
| Gross Debt | R$ 1.89 B |
| Net Debt | R$ 1.23 B |
| Shareholder´s Equity | R$ 784.11 M |
| Share Book Value | R$ 9.45 |
| Common Shares | 82,951,000 |
| Preferred Shares | 0 |
| Total | 82,951,000 |
| Common Shares in Treasury | 0 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 0 |
| Common Shares (Except Treasury) | 82,951,000 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 82,951,000 |
| Updated 11/13/2024 | |
Cash Flow - ORVR3
| Operating Cash Flow | R$ 106.70 M |
| Cash Flow from Investments | - R$ 359.01 M |
| Financing Cash Flow | R$ 563.46 M |
| Increase (Reduction) in Cash and Equivalents | R$ 311.15 M |
| Updated 11/13/2024 | |
| Operating Cash Flow | R$ 27.37 M |
| Cash Flow from Investments | - R$ 291.69 M |
| Financing Cash Flow | R$ 471.67 M |
| Increase (Reduction) in Cash and Equivalents | R$ 207.35 M |
| Updated 11/13/2024 | |
Experimental - ORVR3
| CAPEX 3 months | - R$ 171.58 M |
| Free Cash Flow 3 months | - R$ 144.22 M |
| CAPEX 12 months | - R$ 448.84 M |
| Free Cash Flow 12 months | - R$ 342.14 M |
| Updated 11/13/2024 | |